Harnessing the Membrane Translocation Properties of AB Toxins for Therapeutic Applications

Over the last few decades, proteins and peptides have become increasingly more common as FDA-approved drugs, despite their inefficient delivery due to their inability to cross the plasma membrane. In this context, bacterial two-component systems, termed AB toxins, use various protein-based membrane...

Description complète

Détails bibliographiques

Auteurs principaux:	Numa Piot, F. Gisou van der Goot, Oksana A. Sergeeva
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2021-01-01
Collection:	Toxins
Sujets:	botulinum toxin anthrax toxin cholera toxin membrane translocation endocytosis therapeutic applications
Accès en ligne:	https://www.mdpi.com/2072-6651/13/1/36
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!